Daihan Pharmaceutical Co.,Ltd.

₩24,700As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:023910Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 0.04%
Div yield 3.64%
ROE 9.29%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.13
PE TTM 5.276
TSR TTM (12.07%)
Mkt cap ₩145.2B
ROIC 12.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩24,140
(2.27%)
(56.86%)
Hold 6|11|8|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
451.53
458.59
490.96
473.01
14.58%
16.38%
14.42%
(0.32%)
Revenue₩B
6.449
6.353
6.193
6.349
(2.73%)
(5.00%)
(7.61%)
(3.36%)
Peers (US$107.1M)
Cap (US$)
PE
106.9M
26.43x
106.3M
3.616x
105.2M
7.897x
Capital
TTM
5Y
10Y
Leveragex
1.291
(0.084)
(0.075)
EBIT/Intx
1.055
1.859
1.733
Own earn%
13.17
19.64
11.97
Sh yield%
41.24
16.52
18.03
Owners
Insiders/Inst%
11.37
24.43
Short interest%
3.61
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
20–23
$1 testx
—
Incr. ROIC%
12